Literature DB >> 25064768

Low plasma renalase concentration in hypertensive patients after surgical repair of coarctation of aorta.

Maciej T Wybraniec1, Katarzyna Mizia-Stec2, Olga Trojnarska3, Jerzy Chudek4, Beata Czerwieńska5, Maria Wikarek4, Andrzej Więcek5.   

Abstract

The study aimed to evaluate plasma renalase level, a recently discovered kidney-derived catecholamine-metabolizing enzyme in patients after successful repair of aortic coarctation, with special consideration of arterial hypertension in the context of underlying process of arterial remodeling. This case-control study covered 50 consecutive patients after Dacron patch repair of aortic coarctation (31 men; median age 33 [26; 40]; age at surgery 10 [5; 16] years), matched in terms of age and gender with 50 controls. Both groups were stratified depending on the presence of hypertension and assessed in terms of renalase, C-reactive protein, and carotid intima-media thickness. Additionally ultrasound and tonometric markers of vascular remodeling were obtained in the study group. Hypertension was found in 21 patients (42%) in the study group and 29 (58%) in the control group (P = .11). Renalase level was significantly lower in patients in the study than control group (5825.1 vs. 6592.7 ng/mL; P = .041). Significant difference in terms of renalase concentration between hypertensive and normotensive patients was confirmed both in subjects with coarctation of aorta (P = .027) and in control group (P < .0001). Renalase level inversely correlated with serum creatinine (r = -0.36) and arterial blood pressure in the whole population, and with central systolic (r = -0.29) and diastolic pressure (r = -0.35) in study group. Multivariate regression revealed that serum creatinine and pulse pressure were independent predictors of renalase. Surgical intervention >7 years was linked to lower renalase (P = .018) and unfavorable vascular parameters. Renalase level <4958 ng/mL accurately predicted presence of hypertension in patients after coarctation of aorta repair (odds ratio, 3.8; P = .032). Renalase deficiency is associated with the presence of hypertension in both patients after surgical repair of aortic coarctation and the control group. In coarctation of aorta, its action is probably parallel to underlying arterial remodeling.
Copyright © 2014 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aortic coarctation; arterial hypertension; arterial remodeling; catecholamine metabolism

Mesh:

Substances:

Year:  2014        PMID: 25064768     DOI: 10.1016/j.jash.2014.04.009

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  8 in total

1.  The role of urinary renalase on early-stage renal damage in Chinese adults with primary hypertension.

Authors:  Na-Na You; Wei-Hong Jiang; Ming-Yuan Lin; Xiao-Gang Li; Yu-Yan Wu; Jia-Ying Li; Xiao-Yu Zhou; Ze-Wen Ding; Jun-Wen Wang; Xie-Xiong Zhao; Hui-Ling Chen; Hui-Ting Tang
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-26

2.  Association of Serum Renalase Levels and Renalase rs10887800 Polymorphism with Unstable Angina Pectoris Patients Having Metabolic Syndrome.

Authors:  Peyman Izadpanah; Fatemeh Asadian; Ali Jangjou
Journal:  Diabetes Metab Syndr Obes       Date:  2020-09-15       Impact factor: 3.168

Review 3.  Renalase and Biomarkers of Contrast-Induced Acute Kidney Injury.

Authors:  Maciej T Wybraniec; Katarzyna Mizia-Stec
Journal:  Cardiorenal Med       Date:  2015-09-19       Impact factor: 2.041

4.  Effects and Mechanisms of Radiofrequency Ablation of Renal Sympathetic Nerve on Anti-Hypertension in Canine.

Authors:  Wei Chen; Xiaohong Tang; Xiaofang Yang; Chunyan Weng; Kan Yang; Juan Wen; Hong Liu; Yang Wu
Journal:  Arq Bras Cardiol       Date:  2017-03-06       Impact factor: 2.000

5.  CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis.

Authors:  Klaudia Gieszczyk-Strózik; Maciej T Wybraniec; Małgorzata Widuchowska; Ligia Brzezińska-Wcisło; Przemysław Kotyla; Eugeniusz Kucharz; Katarzyna Mizia-Stec
Journal:  Sci Rep       Date:  2021-10-01       Impact factor: 4.379

6.  Association of renalase with clinical outcomes in hospitalized patients with COVID-19.

Authors:  Basmah Safdar; Melinda Wang; Xiaojia Guo; Charles Cha; Hyung J Chun; Yanhong Deng; James Dziura; Joe M El-Khoury; Fred Gorelick; Albert I Ko; Alfred I Lee; Robert Safirstein; Michael Simonov; Bin Zhou; Gary V Desir
Journal:  PLoS One       Date:  2022-03-08       Impact factor: 3.240

7.  Associations of Renalase With Blood Pressure and Hypertension in Chinese Adults.

Authors:  Yang Wang; Chen Chen; Gui-Lin Hu; Chao Chu; Xiao-Yu Zhang; Ming-Fei Du; Ting Zou; Qing Zhou; Yue-Yuan Liao; Qiong Ma; Ke-Ke Wang; Yue Sun; Dan Wang; Yu Yan; Yan Li; Hao Jia; Ze-Jiaxin Niu; Xi Zhang; Lan Wang; Zi-Yue Man; Wei-Hua Gao; Chun-Hua Li; Jie Zhang; Ke Gao; Hui-Xian Li; John Chang; Gary V Desir; Wan-Hong Lu; Jian-Jun Mu
Journal:  Front Cardiovasc Med       Date:  2022-02-24

8.  Serum Renalase Levels in Adolescents with Primary Hypertension.

Authors:  Marta Lemiesz; Edyta Tenderenda-Banasiuk; Dorota Sosnowska; Katarzyna Taranta-Janusz; Anna Wasilewska
Journal:  Pediatr Cardiol       Date:  2018-05-10       Impact factor: 1.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.